BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey
Company Hits Construction Milestone for Flagship Manufacturing and R&D Facility in Hopewell BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, is entering a new phase
Source: finanznachrichten.de